Stocks to Watch August 21 2025 – Top NSE & BSE Updates Today

Jupiter Wagons Limited (JWL)

Jupiter Wagons bags ₹215 Crore Vande Bharat Order

• Among the Stocks to Watch August 21 2025, Jupiter Wagons’ subsidiary has won an order worth ₹215 crore to supply 5,376 wheelsets (the wheels and axles used in trains).
• These wheelsets will be used in Vande Bharat trains, India’s premium semi-high-speed trains.
• This will show strong demand in the railway sector and could boost the company’s revenue and profits.

Fortis Healthcare Limited (FORTIS)

Fortis Healthcare to Build 550-Bed Hospital in Lucknow

• Fortis Healthcare also features in today’s Stocks to Watch August 21 2025 list, has signed an agreement with Ekana Group to manage a new 550-bed hospital in Lucknow.
• The hospital will provide advanced treatments and become a “Centre of Excellence” for critical care.
• This will be Fortis’ third major hospital in Uttar Pradesh, showing their plan to expand healthcare access in North India.
• For investors: A bigger hospital network means higher patient flow and revenue growth.

Godrej Agrovet Limited (GODREJAGRO)

Godrej Agrovet Launches New Herbicide “Ashitaka” for Maize Farmers

• Among the Stocks to Watch August 21 2025,Godrej Agrovet launched a new herbicide called Ashitaka, developed with a Japanese company.
• It helps farmers protect maize crops by killing weeds that reduce crop yield.
• Why important: Maize is the 4th largest crop in India, used in food, animal feed, and even biofuels. Weeds reduce yields heavily—Ashitaka aims to solve this problem.
• The product starts in Telangana, Karnataka, and Tamil Nadu and will soon spread to all maize-growing states.
• For investors: New products strengthen Agrovet’s market share and profitability in agri-chemicals.

Infosys Limited (INFY)

Infosys Helps Australian Finance Firm Go Fully Digital

• Infosys Finacle, part of Infosys, has helped Uniting Financial Services (UFS), Australia move its entire banking operations to the cloud in just five months.
• They now use Infosys’ Digital Banking Suite hosted on Amazon Web Services (AWS).
• What it means: Customers can access faster, safer, and more modern banking services on mobile and online platforms.
• For investors: This shows Infosys’ strength in global digital transformation projects, adding to its international credibility.

NTPC Limited (NTPC)

NTPC Green Energy Adds More Solar & Wind Power

• NTPC’s renewable energy arm made 212.5 MW solar power operational at its Khavda project in Gujarat.
• Also, a 52.8 MW wind project in Gujarat is now live.
• With these, NTPC’s total capacity reached 83,242 MW.
• For investors: Expanding renewable capacity shows NTPC is preparing for a future beyond coal, making it a greener and more sustainable power company.

Computer Age Management Services Limited (CAMS)

RBI Approves CAMS’ Payment Business Transfer

• CAMS (Computer Age Management Services) has received RBI approval to shift its payment gateway business to its subsidiary, CAMSPay.
• Why important: By separating payments into a new company, CAMS can focus more on growing digital transactions, while keeping core services stable.
• For investors: A separate payments arm may attract new partnerships and growth opportunities in India’s booming digital payments market.

Dr. Lal Path Labs Ltd (LALPATHLAB)

Dr. Lal PathLabs Uses AI for Cancer Detection

• Dr. Lal PathLabs is the first lab in India to use artificial intelligence (AI) to detect cancer spread in lymph nodes.
• The AI tool can even spot micrometastasis (tiny cancer cells invisible to the human eye).
• Why it matters: Faster and more accurate detection means better treatment decisions and higher survival chances for patients.
• For investors: Adoption of advanced AI tech boosts Lal PathLabs’ reputation as a leader in diagnostics, attracting more doctors and patients.

Lupin Limited (LUPIN) & Natco Pharma Limited (NATCOPHARM)

Lupin Global Pharma & NATCO Pharma Launch Rare Disease Drug in US

• Both companies launched Bosentan Tablets (32 mg) in the US.
• The drug treats Pulmonary Arterial Hypertension (PAH) – a rare and serious condition where blood pressure is too high in the lungs.
• They received 180-day exclusivity, meaning no other generic competitors can sell this drug for 6 months.
• The US market for this drug is worth ~USD 10 million annually.
• For investors: Exclusive rights = higher sales and profits in the short term.

Shree Cement Ltd (SHREECEM)

Shree Cement’s Tax Demand Reduced by ₹367 Crore

• Earlier, the Income Tax department had demanded ₹588.65 crore from Shree Cement for FY22.
• After review, the demand has been reduced to ₹221.72 crore.
• The company has already cleared this by adjusting it against refunds owed to them.
• Shree Cement is appealing further, hoping the tax demand may reduce even more.
• For investors: A lower tax demand removes a big financial burden and reduces uncertainty.

That wraps up our Stocks to Watch August 21 2025 report. Stay tuned for daily updates on NSE and BSE-listed companies that matter to investors.